register

Market Research & Insights

Impact of COVID-19 pandemic on medical devices market

Health Industry Hub | April 27, 2020 |

Market Research & Insights: The COVID-19 pandemic is leading to significant growth in demand for medical devices such as ventilators, medical clothing, face masks, and diagnostic devices such as test kits, whereas the revenue of companies, whose products rely heavily on elective and non-essential procedures, are expected to be impacted negatively.

Many medical device companies have revised their financial guidance for 2020 due to the uncertainty associated with the degree and duration of the impact of the outbreak.

The short-term impact of COVID-19 is expected to cause a decline in annual growth rate of the global medical devices market from 5.4% to 3.0% in 2020. The global medical devices market, which was projected to be worth USD 472 billion in 2020 before the COVID-19 outbreak, is now expected to generate USD 461 billion this year.

Customer engagement during COVID-19. Fill the gap of reduced field force activities. Health Industry Hub combines expertise in delivering digital health content with high engagement and 20+ years industry experience. Created by industry for industry. Contact us.

Key Reasons for the Impact

Delay in Elective Surgery

Elective procedures have been delayed as countries divert their healthcare resources to contain the COVID-19 pandemic.

The impact of the delay in elective procedures on the demand for medical devices is significant as these types of procedures account for around 40% – 50% of the hospital’s revenues in some countries.

Supply Chain Disruptions

The supply of medical devices or the raw material required for the manufacturing of medical devices have been disrupted as many countries went into lock-down. The forced quarantine in China hit the supply-chain the hardest as the country transitioned from being a key player in the manufacturing of low-end to high-end medical devices.

With a significant increase in the demand for certain medical devices, some countries halted exports, especially the devices that are vital in fighting against the COVID-19 outbreak.

Impact of China

Register FREE and join 22,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

China, which accounted for around 7% of the global medical devices market, was projected to grow at a CAGR of around 10% in the 2018 – 2025 period before the outbreak. The demand for medical devices is expected to decline considerably in the first quarter of 2020 in China and impact the revenues of all major medical device companies.

Segments with Low Level Exposure to COVID-19

  • In-vitro Diagnostics
  • Diagnostic Imaging
  • Respiratory Care
  • General Hospital and Healthcare Supplies

Segments with High Level Exposure to COVID-19

  • Orthopaedic Devices
  • Cardiovascular Devices
  • Minimally Invasive Surgical Devices
  • Dental Equipment and Devices
  • Diabetes Care Devices
  • Ophthalmic Devices

News & Trends - Pharmaceuticals

Manoj Saxena - Bayer

Breaking the mold: Bayer GM on the future of pharma workplaces – Reimagining Healthcare Senior Leadership Series

Health Industry Hub | July 18, 2024 |

In the latest episode of the Reimagining Healthcare senior leadership series, Manoj Saxena, General Manager Pharmaceuticals ANZ at Bayer voiced […]

More


News & Trends - Pharmaceuticals

Matt Zeller, Country President of Novartis ANZ

Novartis Country President talks essentials in shaping the future of health policy: Reimagining Healthcare senior leadership series

Health Industry Hub | July 18, 2024 |

In this episode of the Reimagining Healthcare senior leadership series, Matt Zeller, Country President of Novartis ANZ, explores how health […]

More


Medical

First guidelines to stamp out rising scientific integrity issues in medical journals

First guidelines to stamp out rising scientific integrity issues in medical journals

Health Industry Hub | July 18, 2024 |

The number of retractions issued for scientific research articles in 2023 exceeded 10,000 – smashing annual records. To date, publishers […]

More


News & Trends - Pharmaceuticals

Gilead secures MSAC nod for CAR-T therapy

Gilead secures MSAC nod for CAR-T therapy

Health Industry Hub | July 18, 2024 |

Pharma News: Gilead Sciences welcomes the Medical Services Advisory Committee (MSAC) recommendation for public funding of Yescarta (axicabtagene ciloleucel) as […]

More


This content is copyright protected. Please subscribe to gain access.